Concepedia

Katie Kanter

KK

Statistics

Publications

8

Citations

768

H-Index

8

Active since

2019

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Katie Kanter is an author at Massachusetts General Hospital specializing in cancer therapeutics, colorectal cancer, and tumor biology.

ORCID

Top concepts

Publications per year

2019–2023

8

Publications

8

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Aparna R. Parikh, Emily E. Van Seventer, Giulia Siravegna et al. · Clinical Cancer Research · 2021 · 331 citations · Full text

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Jun Tian, Jonathan Chen, Sherry Chao et al. · Nature Medicine · 2023 · 164 citations · Full text

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Aparna R. Parikh, Amikasra Mojtahed, Jaime L. Schneider et al. · Clinical Cancer Research · 2020 · 137 citations · Full text

SO-26 Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients

Ryan B. Corcoran, Marios Giannakis, Jill N. Allen et al. · Annals of Oncology · 2020 · 43 citations · Full text

, , +8

Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia

Katie Kanter, Ryan S. Gallagher, Feyisope Eweje et al. · Harm Reduction Journal · 2021 · 36 citations · Full text

1–5 of 8